Investigation of Leukocyte Trafficking Into Skin Blisters During Cardiopulmonary Bypass
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
|Official Title:||Investigation of Leukocyte Trafficking Into Skin Blisters During Cardiopulmonary Bypass|
- Comparison of the number of extravasated leukocytes in the skin blisters pre- and post-operatively, in both the placebo and aprotinin treatment groups
- The activation status of the blister leukocytes and the level of soluble inflammatory mediators within the blister
|Study Start Date:||January 2003|
|Estimated Study Completion Date:||June 2005|
It has long been known that exposure of blood to the heart-lung bypass machine can trigger a whole-body inflammatory response in cardiac surgery patients that is linked to activation of circulating white blood cells. The investigators propose to use a technique to track the movement of white blood cells into the skin of patients during bypass surgery. The skin blisters will be elicited by application of the blistering agent cantharidin to the forearm of volunteer patients. This will allow the investigators to study the activation state of white blood cells that enter tissues during bypass surgery and to determine whether aprotinin has any beneficial effect with regards to inflammatory status of these cells.
The investigators propose that white blood cell trafficking into the blisters will increase following the use of the heart-lung machine and that the effect of aprotinin will be to ablate this.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00131040
|London, United Kingdom, W12 0NN|
|Principal Investigator:||Kenneth M Taylor, MD, FRCS||Hammersmith Hospital Campus, Imperial College|